The relationship between dual antiplatelet treatment (DAPT) score and saphenous venous grafts patency after coronary artery bypass grafting surgery. Issue 7 (2nd November 2021)

• Record Type: Journal Article
• Authors: Bayam, Emrah; Öztürkeri, Burak; Yıldırım, Ersin; Kalçık, Macit; Küp, Ayhan; Çakmak, Ender Özgün; Günay, Nuran; Güner, Ahmet; Kalkan, Semih; Karaduman, Ahmet; Kahyaoğlu, Muzaffer; Zehir, Regayip
• Is Part Of: Acta cardiologica. Volume 76:Issue 7(2021)
• Page Start: 785
• Page End: 791
• Publication Date: 2021-11-02
• Subjects: Coronary artery bypass grafting (CABG) -- coronary artery disease -- dual antiplatelet treatment (DAPT) score -- saphenous venous graft (SVG) patency; Cardiology -- Periodicals; Cardiology; Cardiologie -- Périodiques; Cardiology; Cardiologie; Periodicals; Periodicals; 616.12005
• DOI: 10.1080/00015385.2021.1912248
• Languages: English
• ISSNs: 0001-5385

Abstract

Abstract: Background: Coronary artery bypass grafting (CABG) remains the gold standard treatment for mutivessel and left main coronary artery disease (CAD). Saphenous vein graft (SVG) patency is still a problem in CAD patients after CABG surgery. The Dual Antiplatelet Treatment (DAPT) score is a clinical prediction tool that predicts ischaemic and bleeding risk in CAD patients. The aim of this study is to investigate the relationship between DAPT score and SVG patency in CABG patients. Method: This retrospective study enrolled a total of 398 patients (68 female; mean age 65.8 ± 9.1 years) with a history of CABG surgery. The study population was divided into two subgroups according to SVG patency. The DAPT score was calculated for each patients and compared between the two groups. Results: Coronary angiography revealed SVG disease in 212 patients and SVG patency in 186 patients. The rates of diabetes mellitus and hypertension, red cell distribution width values, DAPT Score, time interval after CABG and number of SVGs were significantly higher while LVEF was significantly lower in patients with SVG disease. The presence of diabetes mellitus, high DAPT score, long time interval after CABG and high number of SVGs were found to be independent predictors of SVG patency. DAPT score above 2.5 predicted SVG disease with a sensitivity of 77.1% and a specificity of 87.1% (AUC: 0.873; 95%CI: 0.823–0.924; p < 0.001). Conclusion: The DAPT score may provide useful information for SVG patency in CABG patients. Patients with high DAPT score should be followed up closely for SGV occlusion. DAPT score may be useful prior to CABG in determining the duration of dual anti-platelet therapy and in encouraging the use of arterial grafts with better patency.